Viemed Healthcare Inc.

VMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.88

+$0.03 (+0.34%)

Sep 22, 2026, 1:24 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $337.08M

Enterprise Value $338M

Beta 1.09

Average Volume 339.97K

Shares Outstanding (Diluted) 41.13M

Shares Change YoY 0.1%

Institutional Ownership 64.77%

Exchange NASDAQ

ISIN CA92663R1055

Price Performance

Price Change 1M -2.2%

Price Change 3M -19.1%

Price Change 6M -5.3%

Price Change YTD 22.6%

Price Change 1Y 27.7%

Price Change 3Y 23.8%

Price Change 5Y 47.8%

1M CAGR (ann.) -9.0%

1Y CAGR (ann.) 30.3%

5Y CAGR (ann.) 7.5%

All-Time CAGR 20.1%

Valuation

PE Ratio 24.58

Forward PE 15.35

PEG Ratio 4.22

Forward PEG 0.75

PS Ratio 1.12

Forward PS 1.00

PB Ratio 2.34

P/FCF Ratio 11.02

P/Adj. FCF Ratio 17.57

P/OCF Ratio 5.57

EV/Sales 1.12

EV/EBIT 14.46

EV/EBITDA 6.30

EV/FCF 11.05

Earnings Yield 4.1%

FCF Yield 9.1%

Adj. FCF Yield 5.7%

Financial Health

Net Cash $2.17M

Total Debt $11.6M

Cash & Short-Term Investments $10.68M

Total Assets $204.22M

Current Ratio 1.13

Quick Ratio 1.02

Debt / Equity Ratio 0.08

Debt / EBITDA 0.22

Debt / FCF 0.38

OCF / Debt 5.94

Interest Coverage 17.25

Altman Z-Score 6.10

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 57.2%

Operating Profit Margin 8.1%

EBITDA Margin 17.8%

Net Profit Margin 4.8%

FCF Margin 10.1%

Adj. FCF Margin 6.4%

SBC / Revenue 3.0%

SBC Impact (per share) -37.3%

Returns

Return on Assets 7.1%

Return on Equity 10.3%

Return on Invested Capital 11.0%

Return on Capital Employed 15.7%

Return on Tangible Assets 10.1%

Historical Growth (CAGR)

Revenue CAGR 3Y 24.5%

Revenue CAGR 5Y 20.1%

Revenue CAGR 10Y 22.8%

EPS CAGR 3Y 26.0%

EPS CAGR 5Y 5.9%

EPS CAGR 10Y -13.0%

FCF CAGR 3Y 40.2%

FCF CAGR 5Y 26.2%

FCF CAGR 10Y 2.6%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 3, 2026

EPS Estimate (next Q) $0.12

EPS Growth Est (next Q) 33.3%

Revenue Est (next Q) $80.78M

Revenue Growth Est (next Q) 12.3%

Fair Value Estimates

Graham Number $5.56

Graham Upside -37.2%

Lynch Fair Value $2.13

Lynch Upside -75.9%

Price Target $14

Price Target Upside 58.2%

Cash Flow

Operating Cash Flow $68.85M

Free Cash Flow $30.6M

Adj. Free Cash Flow $19.18M

FCF Per Share $0.76

OCF Per Share $1.59

OCF/S Ratio 20.2%

Income Statement

Revenue $301.61M

Gross Profit $172.55M

Operating Income $24.56M

EBITDA $53.62M

Net Income $14.5M

EPS (Diluted) $0.36

Revenue / Employee $209.74K

Profit / Employee $10.08K

Employees 1,438